financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lowers Opinion On Shares Of Tesla Inc. To Sell From Hold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lowers Opinion On Shares Of Tesla Inc. To Sell From Hold
Sep 15, 2025 6:33 PM

02:50 PM EDT, 09/15/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain a 12-month target of $300, based on a 2026 P/E of 146x, justified by long-term growth expectations. We lower our opinion on TSLA to Sell, as we believe the stock's valuation has become decoupled from fair value and underlying fundamentals. We think the Street's estimates will be revised lower in the coming months as the bottom line impacts of the One Big Beautiful Bill become more apparent. We lower our 2025 EPS view to $1.40 from $1.70 and 2026's to $2.05 from $2.60. Our concerns are more centered on the expected impacts on TSLA's auto regulatory credit revenue, a high-margin, fast-growing revenue stream (+54% to $2.76B in 2024). While news of CEO Elon Musk's $1B stock purchase sends a positive signal to investors, we view it as more of vote of confidence in TSLA longer term (a duration longer than the 12-month timeframe that is the basis of our price target). We think Musk's acknowledgment of the possibility of "a few rough quarters" ahead on the last earnings call should not be taken lightly.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Downgrades Opinion On Shares Of Alcoa Corporation To Hold From Buy
Research Alert: CFRA Downgrades Opinion On Shares Of Alcoa Corporation To Hold From Buy
Jul 17, 2025
02:20 PM EDT, 07/17/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We decrease our 12-month target price by $5 to $32, using an EV/EBITDA of 5.0x our 2026 EBITDA estimate, below peers' average forward EV/EBITDA of 5.8x and AA's three-year average...
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Elevance Health
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Elevance Health
Jul 17, 2025
03:05 PM EDT, 07/17/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target to $331 from $450, reflecting a 10.8x multiple of our 2026 EPS forecast, a discount to historical due to unfavorable medical cost trends. ELV reports...
Research Alert: CFRA Keeps Buy Opinion On Adss Of Jd.com, Inc.
Research Alert: CFRA Keeps Buy Opinion On Adss Of Jd.com, Inc.
Jul 17, 2025
01:40 PM EDT, 07/17/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our target price of USD37 (from USD50) is 13x 2026 EV/EBITDA, comparable to the peer average, balancing JD's stronger e-commerce business with business uncertainties in food delivery. We forecast revenue...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Kinder Morgan Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Kinder Morgan Inc.
Jul 17, 2025
03:35 PM EDT, 07/17/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $31, cut by $4, reflects a combination of a relative valuation model ($30 per share, based on an 11.5x multiple of enterprise value to projected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved